Literature DB >> 4207732

The binding of alpha-1 antitrypsin to human IgA.

T B Tomasi, S P Hauptman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4207732

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  12 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors: 
Journal:  Am J Dig Dis       Date:  1975-06

2.  Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.

Authors:  J Biewenga; A Faber; J C Pronk; J J Haaijman
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  IgA paraprotein inhibition of human neutrophil chemotaxis. Reduced activity following treatment with IgA-specific protease from Neisseria gonorrhoeae.

Authors:  D E Van Epps; A Plaut; G M Bernier; R C Williams
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

4.  Inhibition of human eosinophil chemotaxis by IgA paraproteins.

Authors:  K J Reed; D E Van Epps; R C Williams
Journal:  Inflammation       Date:  1979-09       Impact factor: 4.092

5.  Does the serum level of IgA-alpha-1-antitrypsin complex correlate with radiological progression in early rheumatoid arthritis? A 3-year follow-up study.

Authors:  J K Lacki; T Schochat; W Porawaska; S H Mackiewicz; W Müller
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 6.  Macroamylasemia and other immunoglobulin-complexed enzyme disorders.

Authors:  D C Klonoff
Journal:  West J Med       Date:  1980-11

7.  Protein contents and binding modes of immunoglobulin-amylase complexes.

Authors:  H Ohtani; K Sakaguchi; M Saito
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

8.  Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans.

Authors:  R C Monteiro; H Kubagawa; M D Cooper
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

9.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.